MSTN and diabetes mellitus: To this end, it is possible that diabetes, by increasing ROS generation and reducing antioxidant scavenging capacity, triggers a state of heightened oxidative stress; this phenomenon in turn activates both FoxO-atrogin and myostatin-TGF-β related pathways leading to a high rate of muscle wasting and henceforth sarcopenia.